https://be.milliman.com/nl-BE 2026-03-10 https://be.milliman.com/nl-BE/accessibility-statement 2024-12-15 https://be.milliman.com/nl-BE/Health 2024-12-15 https://be.milliman.com/nl-BE/Whistleblower 2024-12-15 https://be.milliman.com/nl-BE/Whistleblower-privacy-policy 2024-12-15 https://be.milliman.com/nl-BE/Insurance 2024-12-15 https://be.milliman.com/nl-BE/Cookie-Policy 2024-12-15 https://be.milliman.com/nl-BE/Data-Science-Artificial-Intelligence 2025-12-24 https://be.milliman.com/nl-BE/Insight 2024-12-15 https://be.milliman.com/nl-BE/Privacy-Policy 2024-12-15 https://be.milliman.com/nl-BE/Copyright-Information 2024-12-15 https://be.milliman.com/nl-BE/Terms-of-Use 2024-12-15 https://be.milliman.com/nl-BE/News-and-Events 2024-12-15 https://be.milliman.com/nl-BE/Our-Story 2024-12-15 https://be.milliman.com/nl-BE/Experts 2024-12-15 https://be.milliman.com/nl-BE/Search 2024-12-15 https://be.milliman.com/nl-BE/Social-Impact 2024-12-15 https://be.milliman.com/nl-BE/Office-Locations 2024-12-15 https://be.milliman.com/nl-BE/404 2024-12-15 https://be.milliman.com/nl-BE/Health/Health-products 2024-12-15 https://be.milliman.com/nl-BE/Health/Health-services 2024-12-15 https://be.milliman.com/nl-BE/Insurance/Climate-Change 2024-12-15 https://be.milliman.com/nl-BE/Insurance/IFRS-17 2024-12-15 https://be.milliman.com/nl-BE/Insurance/Solvency-II 2024-12-15 https://be.milliman.com/nl-BE/Products/acoinsight 2024-12-15 https://be.milliman.com/nl-BE/Products/Health-Cost-Guidelines-Suite 2024-12-15 https://be.milliman.com/nl-BE/Products/ACO-Care-Management-Impact-Model 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Inpatient-Benchmarking-Tool 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Mind 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-PinPoint 2024-12-15 https://be.milliman.com/nl-BE/Products/economic-scenario-generator 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Health-Trend-Guidelines 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-IFRS-17-Readiness-Assessment-Tool 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Intelliscript 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Medical-Underwriting-Suite 2024-12-15 https://be.milliman.com/nl-BE/Products/Datalytics-Defense 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-STAR-Solutions 2024-12-15 https://be.milliman.com/nl-BE/Products/NAVI 2026-01-20 https://be.milliman.com/nl-BE/Products/Pension-Performance-Dashboard 2024-12-15 https://be.milliman.com/nl-BE/Products/REVEAL 2024-12-15 https://be.milliman.com/nl-BE/Products/Small-Group-Medical-Underwriting-Guidelines 2024-12-15 https://be.milliman.com/nl-BE/Products/Solvency-II-Compliance-Assessment-Tool 2024-12-15 https://be.milliman.com/nl-BE/Products/VEGA 2024-12-15 https://be.milliman.com/nl-BE/Products/VoVA 2024-12-15 https://be.milliman.com/nl-BE/Products/WebMUGs 2024-12-15 https://be.milliman.com/nl-BE/Products/Bundled-Payment-Reporting-Interface 2024-12-15 https://be.milliman.com/nl-BE/Products/Claim-Reserve-Estimation-Workbook 2024-12-15 https://be.milliman.com/nl-BE/Products/DRIVE 2024-12-15 https://be.milliman.com/nl-BE/Products/Excess-Product-Suite 2024-12-15 https://be.milliman.com/nl-BE/Products/Healthcare-Reform-Dashboard 2024-12-15 https://be.milliman.com/nl-BE/Products/Hospital-Performance-Index 2024-12-15 https://be.milliman.com/nl-BE/Products/Individual-Medical-Underwriting-Guidelines-IMUGs 2024-12-15 https://be.milliman.com/nl-BE/Products/Recon 2024-12-15 https://be.milliman.com/nl-BE/Products/MARA 2024-12-15 https://be.milliman.com/nl-BE/Products/Medicare-Advantage-Competitive-Value-Added-Tool 2024-12-15 https://be.milliman.com/nl-BE/Products/Milliman-Mind-IFRS17 2024-12-15 https://be.milliman.com/nl-BE/Insight/europe-insight 2024-12-15 https://be.milliman.com/nl-BE/Insight/Health-insight 2024-12-15 https://be.milliman.com/nl-BE/Insight/Insurance-insight 2024-12-15 https://be.milliman.com/nl-BE/Insight/Retirement-benefits-insight 2024-12-15 https://be.milliman.com/nl-BE/Insight/Risk-insight 2024-12-15 https://be.milliman.com/nl-BE/Insight/SFCR 2025-11-18 https://be.milliman.com/nl-BE/News-and-Events/Infographic-archive 2024-12-15 https://be.milliman.com/nl-BE/Periodicals/Benefits-Perspectives 2024-12-15 https://be.milliman.com/nl-BE/Periodicals/eiopa-consultations-and-the-solvency-ii-review 2026-01-29 https://be.milliman.com/nl-BE/Periodicals/DB-Digest 2024-12-15 https://be.milliman.com/nl-BE/Periodicals/Monthly-Benefit-News-and-Developments 2024-12-15 https://be.milliman.com/nl-BE/Periodicals/Multiemployer-Review 2024-12-15 https://be.milliman.com/nl-BE/Periodicals/PeriScope 2024-12-15 https://be.milliman.com/nl-BE/News-and-Events/Press-release-archive/2020-press-releases 2024-12-15 https://be.milliman.com/nl-BE/News-and-Events/Press-release-archive/2021-press-releases 2024-12-15 https://be.milliman.com/nl-BE/insight/data-quality-insurance-machine-learning-ai-improvement 2026-03-20 https://be.milliman.com/nl-BE/insight/extreme-weather-events-in-europe-2025 2026-04-01 https://be.milliman.com/nl-BE/insight/european-health-cost-trends 2026-02-18 https://be.milliman.com/nl-BE/insight/eiopa-consultations-solvency-ii-review-3 2026-01-30 https://be.milliman.com/nl-BE/insight/eiopa-consultations-solvency-ii-review-4 2026-01-30 https://be.milliman.com/nl-BE/insight/2025-orsa-sustainability-benchmarking-european-stress-tests 2026-01-26 https://be.milliman.com/nl-BE/insight/modeling-future-pandemic-risk-r-shiny 2026-01-16 https://be.milliman.com/nl-BE/insight/where-is-europe-next-flash-flood 2025-12-18 https://be.milliman.com/nl-BE/insight/actuaries-insurance-linked-securities-market 2025-12-17 https://be.milliman.com/nl-BE/insight/streamlining-scenario-testing-framework 2025-12-02 https://be.milliman.com/nl-BE/insight/2024-sfcr-belgium 2025-11-04 https://be.milliman.com/nl-BE/insight/ifrs-17-benchmarking-fy-2024-report 2025-06-06 https://be.milliman.com/nl-BE/insight/extreme-weather-events-in-europe-2024 2025-05-21 https://be.milliman.com/nl-BE/insight/life-and-health-insurance-mergers-and-acquisitions-2025 2025-05-20 https://be.milliman.com/nl-BE/insight/barometer-of-gen-ai-adoption-europe-insurance 2025-05-12 https://be.milliman.com/nl-BE/insight/critical-point-60-cost-extreme-weather-europe 2025-06-03 https://be.milliman.com/nl-BE/insight/comparative-analysis-life-insurance-achmea-asr-athora-nn 2025-06-10 https://be.milliman.com/nl-BE/insight/navigating-new-volatility-adjustment-framework 2026-02-05 https://be.milliman.com/nl-BE/insight/2023-sfcr-life-non-life-composite-belgium 2025-04-03 https://be.milliman.com/nl-BE/insight/trends-in-customer-treatment-regulation 2025-01-31 https://be.milliman.com/nl-BE/insight/eu-ai-act-impact-on-insurance 2025-01-31 https://be.milliman.com/nl-BE/insight/ifrs-17-benchmarking-europe-fy-2023 2025-01-31 https://be.milliman.com/nl-BE/insight/2023-2024-reassessment-natural-catastrophe-risk-standard-formula 2026-01-29 https://be.milliman.com/nl-BE/insight/extreme-weather-events-in-europe-2023 2025-05-21 https://be.milliman.com/nl-BE/insight/life-and-health-insurance-mergers-and-acquisitions-2024 2025-01-31 https://be.milliman.com/nl-BE/insight/milliman-climate-change-reporting-barometer 2025-01-31 https://be.milliman.com/nl-BE/insight/potential-of-large-language-models-insurance-sector 2025-01-31 https://be.milliman.com/nl-BE/insight/potential-portfolio-administration-migration-european-life-insurance-german 2025-01-31 https://be.milliman.com/nl-BE/insight/impact-of-rising-interest-rates-globally-blessing-or-curse-solvency-position 2025-01-31 https://be.milliman.com/nl-BE/insight/market-insight-year-end-2022-sfcr-life-insurers-luxembourg 2026-01-23 https://be.milliman.com/nl-BE/insight/market-insight-sfcr-non-life-insurers-netherlands-year-end-2022 2025-01-31 https://be.milliman.com/nl-BE/insight/market-insight-sfcr-luxembourg-non-life-insurer-ye-2022 2025-01-31 https://be.milliman.com/nl-BE/insight/market-insight-from-year-end-2022-sfcrs-life-insurers-netherlands 2025-01-31 https://be.milliman.com/nl-BE/insight/analysis-sfcr-year-end-2022-belgium-insurers 2025-04-03 https://be.milliman.com/nl-BE/insight/analysis-european-non-life-insurers-sfcr-year-end-2022 2025-01-03 https://be.milliman.com/nl-BE/insight/life-and-health-insurance-mergers-and-acquisitions-2023 2025-01-31 https://be.milliman.com/nl-BE/insight/bridging-the-gap-ifrs-and-solvency-ii-capital-generation 2025-01-31 https://be.milliman.com/nl-BE/insight/pre-emptive-recovery-planning-first-timer-guide 2025-01-31 https://be.milliman.com/nl-BE/insight/extreme-weather-events-in-europe-2022 2025-01-03 https://be.milliman.com/nl-BE/insight/anomaly-detection-techniques-in-fraud-detection 2025-01-31 https://be.milliman.com/nl-BE/insight/new-interest-rate-environment-back-to-normal-part-3 2025-01-31 https://be.milliman.com/nl-BE/insight/The-new-interest-rate-environment-back-to-normal-part-2 2025-01-03 https://be.milliman.com/nl-BE/insight/new-interest-rate-environment-back-to-normal 2025-01-31 https://be.milliman.com/nl-BE/insight/applied-unsupervised-machine-learning-in-life-insurance-data 2025-01-31 https://be.milliman.com/nl-BE/insight/2021-sfcr-non-life-netherlands 2025-01-31 https://be.milliman.com/nl-BE/insight/2021-sfcr-life-netherlands 2025-01-31 https://be.milliman.com/nl-BE/insight/Explainable-AI-in-fraud-detection 2025-01-31 https://be.milliman.com/nl-BE/insight/Improved-mortality-rate-using-ML-and-open-data 2025-01-31 https://be.milliman.com/nl-BE/insight/classification-of-insurance-claim-emails 2025-01-31 https://be.milliman.com/nl-BE/insight/Viewpoint-Managing-euro-zone-sovereign-risk-in-the-face-of-the-pandemic 2024-12-14 https://be.milliman.com/nl-BE/insight/Practical-aspects-of-the-Gender-Directive-for-mortality-insurance 2024-12-14 https://be.milliman.com/nl-BE/insight/Feedback-on-the-QIS-for-IORPs 2024-12-14 https://be.milliman.com/nl-BE/insight/A-new-risk-based-prudential-regime-for-pension-funds 2025-01-31 https://be.milliman.com/nl-BE/insight/Preliminary-QIS-results-on-IORPs 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-Insurance-Contracts-Summary-2013-Exposure-Draft 2024-12-14 https://be.milliman.com/nl-BE/insight/ORSA-An-international-requirement 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-insurance-contracts-Summary-of-feedback-on-the-2013-exposure-draft 2024-12-14 https://be.milliman.com/nl-BE/insight/2013-Embedded-Value-Results-Generating-Value 2024-12-14 https://be.milliman.com/nl-BE/insight/Milliman-Solvency-II-Readiness-Assessment-Tool-First-industry-survey-Ireland--Life-Assur 2024-12-14 https://be.milliman.com/nl-BE/insight/Update-on-IASB-insurance-accounting-project 2024-12-14 https://be.milliman.com/nl-BE/insight/Bradley-M-Smith-Milliman-Chairman-dies-at-59 2024-12-14 https://be.milliman.com/nl-BE/insight/October-2014-update-on-IASB-insurance-accounting-project 2024-12-14 https://be.milliman.com/nl-BE/insight/2014-Mid-Year-Embedded-Value-Results-Generating-Value 2025-01-31 https://be.milliman.com/nl-BE/insight/Capital-management-in-a-Solvency-II-world-A-non-life-perspective 2025-01-31 https://be.milliman.com/nl-BE/insight/Unit-linked-matching-considerations-under-Solvency-II 2025-01-31 https://be.milliman.com/nl-BE/insight/Operational-challenges-of-IFRS4-Phase-2-as-of-November-2014 2024-12-14 https://be.milliman.com/nl-BE/insight/The-final-countdown 2024-12-14 https://be.milliman.com/nl-BE/insight/Usagebased-insurance-Big-data-machine-learning-and-putting-telematics-to-work 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-4-Phase-II-comparison-with-Solvency-II-and-MCEV 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-4-Phase-II-transition 2024-12-14 https://be.milliman.com/nl-BE/insight/Why-risk-management-must-be-agile 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysing-competitor-tariffs-with-machine-learning 2024-12-14 https://be.milliman.com/nl-BE/insight/2014-Embedded-Value-Results-Europe-Generating-Value 2024-12-14 https://be.milliman.com/nl-BE/insight/Stepping-stones-to-ORSA-Looking-beyond-the-preparatory-phase-of-Solvency-II 2024-12-14 https://be.milliman.com/nl-BE/insight/ORSA-process-implementation-for-internal-stakeholders 2024-12-14 https://be.milliman.com/nl-BE/insight/Health-microinsurance-instructional-pricing-tool 2024-12-14 https://be.milliman.com/nl-BE/insight/Put-healthcare-data-to-work-with-benchmarking-analysis 2024-12-14 https://be.milliman.com/nl-BE/insight/2015-mid-year-embedded-value-results---Europe-and-Japan-Generating-value 2025-01-31 https://be.milliman.com/nl-BE/insight/Time-to-move-forwards 2024-12-14 https://be.milliman.com/nl-BE/insight/Life-insurance-risks-Observations-on-Solvency-II-and-the-modeling-of-capital-needs 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-4-Phase-II-Applying-IFRS-9-Financial-Instruments-with-IFRS-4-Insurance-Contracts 2024-12-14 https://be.milliman.com/nl-BE/insight/Milliman-Impact-Actionable-insight-for-business-leaders 2024-12-14 https://be.milliman.com/nl-BE/insight/Challenges-with-Solvency-II-and-its-implementation 2024-12-14 https://be.milliman.com/nl-BE/insight/Extracting-value-from-sales-process-management 2024-12-14 https://be.milliman.com/nl-BE/insight/Comparison-of-treatment-costs-for-breast-cancer-by-tumor-stage-and-type-of-service 2024-12-14 https://be.milliman.com/nl-BE/insight/The-cost-of-inpatient-death-associated-with-acute-coronary-syndrome 2024-12-14 https://be.milliman.com/nl-BE/insight/Nuclear-waste-issues 2024-12-14 https://be.milliman.com/nl-BE/insight/Milliman-RBRVS-for-Hospitals2 2024-12-14 https://be.milliman.com/nl-BE/insight/Cultural-compass 2024-12-14 https://be.milliman.com/nl-BE/insight/2016-reflections-on-the-favorable-cost-benefit-of-lung-cancer-screening 2025-01-23 https://be.milliman.com/nl-BE/insight/Using-the-ODP-bootstrap-model-A-practitioners-guide 2024-12-14 https://be.milliman.com/nl-BE/insight/Achieving-resilience-by-harnessing-people-power 2024-12-14 https://be.milliman.com/nl-BE/insight/Actuarial-approaches-to-modelling-and-mitigating-financial-uncertainty-in-recommending-new 2024-12-14 https://be.milliman.com/nl-BE/insight/Video-Risk-management-is-about-insight-and-agility-not-just-control 2024-12-14 https://be.milliman.com/nl-BE/insight/Milliman-Derivatives-Survey-2017 2024-12-14 https://be.milliman.com/nl-BE/insight/External-certification-of-Solvency-II-More-than-just-good-governance 2024-12-14 https://be.milliman.com/nl-BE/insight/Cost-differences-between-open-and-minimally-invasive-surgery 2024-12-14 https://be.milliman.com/nl-BE/insight/Using-the-Hayne-MLE-models-A-practitioners-guide 2024-12-14 https://be.milliman.com/nl-BE/insight/The-actuary-and-enterprise-risk-management-Integrating-reserve-variability 2024-12-14 https://be.milliman.com/nl-BE/insight/Optimising-non-life-reinsurance-strategy-under-risk-based-capital-measures 2025-01-31 https://be.milliman.com/nl-BE/insight/2015-Embedded-Value-Results-Europe 2024-12-14 https://be.milliman.com/nl-BE/insight/S2AV-A-valuation-methodology-for-insurance-companies-under-Solvency-II 2024-12-14 https://be.milliman.com/nl-BE/insight/Capital-efficient-products-in-the-European-life-insurance-market 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS17-Implementation-A-new-reporting-framework-comes-with-significant-challenges 2024-12-14 https://be.milliman.com/nl-BE/insight/2016-mid-year-embedded-value-results-Europe-and-Japan-Generating-value 2025-01-23 https://be.milliman.com/nl-BE/insight/Overview-and-practical-considerations-of-the-new-insurance-contract-standard-IFRS-17 2024-12-14 https://be.milliman.com/nl-BE/insight/Looking-at-cancer-trends-through-Milliman-UK-Health-Cost-Guidelines 2024-12-14 https://be.milliman.com/nl-BE/insight/A-valuation-methodology-for-M-and-A-transactions 2024-12-14 https://be.milliman.com/nl-BE/insight/Optimisation-Improving-problem-formulation-and-human-interaction 2024-12-14 https://be.milliman.com/nl-BE/insight/Emerging-risk-analytics-Application-of-advanced-analytics-to-the-understanding-of-emergin 2024-12-14 https://be.milliman.com/nl-BE/insight/Transition-to-IFRS-17 2024-12-14 https://be.milliman.com/nl-BE/insight/Fast-calibration-of-the-Libor-Market-Model-with-Stochastic-Volatility-and-Displaced-Diffus 2024-12-14 https://be.milliman.com/nl-BE/insight/Judging-the-appropriateness-of-the-Standard-Formula-under-Solvency-II 2024-12-14 https://be.milliman.com/nl-BE/insight/A-case-for-data-science 2024-12-14 https://be.milliman.com/nl-BE/insight/Lapses-in-concentration 2024-12-14 https://be.milliman.com/nl-BE/insight/Solvency-II-Recalculation-of-the-Transitional-Measure-on-Technical-Provisions 2024-12-14 https://be.milliman.com/nl-BE/insight/2016-Embedded-Value-Results-Europe 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-17-preparedness-2017-survey-feedback 2024-12-14 https://be.milliman.com/nl-BE/insight/Political-risk-insurance-A-primer 2024-12-14 https://be.milliman.com/nl-BE/insight/Comparative-analysis-of-bonus-malus-systems-in-Italy-and-Central-and-Eastern-Europe 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-nonlife-insurers-sfcr-eu-year-end-2017 2025-03-04 https://be.milliman.com/nl-BE/insight/Analysis-of-Belgian-insurers-Solvency-and-Financial-Condition-Reports-Year-end-2016 2024-12-14 https://be.milliman.com/nl-BE/insight/Eurozone-Market-Monitor-31-December-2017 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-life-insurers-first-set-of-Solvency-and-Financial-Condition-Reports-European 2024-12-14 https://be.milliman.com/nl-BE/insight/Making-the-transition-to-IFRS-17 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-Luxembourg-insurers-Solvency-and-Financial-Condition-Reports-Year-end-2016 2025-01-23 https://be.milliman.com/nl-BE/insight/Leadership-in-the-pension-sector-The-power-of-diversity-in-risk-analysis 2024-12-14 https://be.milliman.com/nl-BE/insight/Leadership-in-the-pension-sector-The-role-of-the-traditional-actuary 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS17-coverage-units-for-CSM-amortization 2024-12-14 https://be.milliman.com/nl-BE/insight/Eurozone-Market-Monitor-28-February-2018 2024-12-14 https://be.milliman.com/nl-BE/insight/IFRS-17-Discount-Rates 2024-12-14 https://be.milliman.com/nl-BE/insight/EIOPA-Final-Report-on-its-second-set-of-advice-to-the-European-Commission-on-the-Solvency 2024-12-14 https://be.milliman.com/nl-BE/insight/A-quantum-leap-in-benchmarking-P-and-C-unpaid-claims 2024-12-14 https://be.milliman.com/nl-BE/insight/A-European-insurance-leader-works-with-Milliman-to-process-raw-telematics-data-and-detect 2024-12-14 https://be.milliman.com/nl-BE/insight/EIOPAs-2018-stress-tests-Cyber-risk-questionnaire 2024-12-14 https://be.milliman.com/nl-BE/insight/International-best-practice-benchmarks 2024-12-14 https://be.milliman.com/nl-BE/insight/Pre-emptive-recovery-planning-for-insurers 2025-01-23 https://be.milliman.com/nl-BE/insight/The-cyber-risk-spend-How-do-you-quantify-the-cost-of-cyber-risk--and-your-return-on-inve 2024-12-14 https://be.milliman.com/nl-BE/insight/Shareholder-value-reporting-in-Europe-Year-end-2017 2025-01-23 https://be.milliman.com/nl-BE/insight/IFRS-17-Considerations-for-health-insurers 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-insurers-Solvency-and-Financial-Condition-Reports 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-Luxembourg-insurers-Solvency-and-Financial-Condition-Reports-Year-end-2017 2025-01-23 https://be.milliman.com/nl-BE/insight/Analysis-of-Belgian-insurers-Solvency-and-Financial-Condition-Reports-Year-end-2017 2025-01-23 https://be.milliman.com/nl-BE/insight/Analysis-of-life-insurers-second-set-of-Solvency-and-Financial-Condition-Reports-Europea 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-nonlife-insurers-Solvency-and-Financial-Condition-Reports-European-non 2024-12-14 https://be.milliman.com/nl-BE/insight/Analysis-of-Dutch-insurers-Solvency-and-Financial-Condition-Reports-Year-end-2017 2025-01-23 https://be.milliman.com/nl-BE/insight/Microinsurance-and-rural-development-in-China-A-Q-and-A-with-Associate-Professor-Yi-Yao 2024-12-14 https://be.milliman.com/nl-BE/insight/2018-IFRS-17-Preparedness-Survey-Turkey-and-Europe-highlights 2024-12-14 https://be.milliman.com/nl-BE/insight/The-2020-Solvency-II-Review-and-update-on-earlier-amendments-European-Commission-issues-C 2024-12-14 https://be.milliman.com/nl-BE/insight/2018-IFRS-Preparedness-Survey 2024-12-14